Abstract: The present invention relates to an improved and industrially advantageous process for the preparation of imatinib of formula I, or its mesylate salt with controlled level of genotoxic impurity of formula II, a key intermediate for imatinib.
Year | CBR Date | CBR Number | Renwal Amount | Renwal Date | Normal Due Date | Renwal To | Renwal From | Due Date with Extension | Reneal Certificate Number |
---|---|---|---|---|---|---|---|---|---|
3rd year | 15/10/2018 | 27402 | 4000 | 15/10/2018 | 20/10/2018 | 31/03/2014 | 31/03/2013 | 20/04/2019 | 43186 |
4th year | 15/10/2018 | 27402 | 4000 | 15/10/2018 | 20/10/2018 | 31/03/2015 | 31/03/2014 | 20/04/2019 | 43187 |
5th year | 15/10/2018 | 27402 | 4000 | 15/10/2018 | 20/10/2018 | 31/03/2016 | 31/03/2015 | 20/04/2019 | 43188 |
6th year | 15/10/2018 | 27402 | 4000 | 15/10/2018 | 20/10/2018 | 31/03/2017 | 31/03/2016 | 20/04/2019 | 43189 |
7th year | 15/10/2018 | 27402 | 12000 | 15/10/2018 | 20/10/2018 | 31/03/2018 | 31/03/2017 | 20/04/2019 | 43190 |
8th year | 15/10/2018 | 27402 | 12000 | 15/10/2018 | 20/10/2018 | 31/03/2019 | 31/03/2018 | 20/04/2019 | 43191 |
9th year | 23/03/2019 | 8972 | 12000 | 23/03/2019 | 31/03/2019 | 31/03/2020 | 31/03/2019 | 30/09/2019 | 13081 |
10th year | 26/03/2020 | 10690 | 12000 | 26/03/2020 | 31/03/2020 | 31/03/2021 | 31/03/2020 | 30/09/2020 | 22170 |
11th year | 26/03/2021 | 10597 | 24000 | 26/03/2021 | 31/03/2021 | 31/03/2022 | 31/03/2021 | 30/09/2021 | 20690 |
12th year | 30/03/2022 | 12188 | 24000 | 30/03/2022 | 31/03/2022 | 31/03/2023 | 31/03/2022 | 30/09/2022 | 23264 |
13th year | 27/03/2023 | 14109 | 24000 | 27/03/2023 | 31/03/2023 | 31/03/2024 | 31/03/2023 | 30/09/2023 | 29870 |
14th year | 22/02/2024 | 13061 | 24000 | 22/02/2024 | 31/03/2024 | 31/03/2025 | 31/03/2024 | 30/09/2024 | 47669 |
15th year | -- | -- | -- | -- | -- | -- | -- | -- | -- |
16th year | -- | -- | -- | -- | -- | -- | -- | -- | -- |
17th year | -- | -- | -- | -- | -- | -- | -- | -- | -- |
18th year | -- | -- | -- | -- | -- | -- | -- | -- | -- |
19th year | -- | -- | -- | -- | -- | -- | -- | -- | -- |
20th year | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Application Number | Applicant | Section | Controller | Decision Date | |
---|---|---|---|---|---|
926/DEL/2011 |
Name | Date | |
---|---|---|
1 | 926-DEL-2011-RELEVANT DOCUMENTS [11-08-2023(online)].pdf | 2023-08-11 |
2 | 926-DEL-2011-RELEVANT DOCUMENTS [05-08-2022(online)].pdf | 2022-08-05 |
3 | 926-DEL-2011-RELEVANT DOCUMENTS [30-09-2021(online)].pdf | 2021-09-30 |
4 | 926-DEL-2011-RELEVANT DOCUMENTS [28-04-2020(online)].pdf | 2020-04-28 |
5 | 926-DEL-2011-RELEVANT DOCUMENTS [22-03-2019(online)].pdf | 2019-03-22 |
6 | 926-DEL-2011-IntimationOfGrant20-07-2018.pdf | 2018-07-20 |
7 | 926-DEL-2011-PatentCertificate20-07-2018.pdf | 2018-07-20 |
8 | 926-DEL-2011-Annexure (Optional) [19-07-2018(online)].pdf | 2018-07-19 |
9 | 926-DEL-2011-Written submissions and relevant documents (MANDATORY) [19-07-2018(online)].pdf | 2018-07-19 |
10 | 926-DEL-2011-HearingNoticeLetter.pdf | 2018-06-07 |
11 | 926-DEL-2011-ABSTRACT [30-05-2018(online)].pdf | 2018-05-30 |
12 | 926-DEL-2011-CLAIMS [30-05-2018(online)].pdf | 2018-05-30 |
13 | 926-DEL-2011-FER_SER_REPLY [30-05-2018(online)].pdf | 2018-05-30 |
14 | 926-DEL-2011-OTHERS [30-05-2018(online)].pdf | 2018-05-30 |
15 | 926-DEL-2011-FER.pdf | 2018-03-05 |
16 | Final__926__DEL_2011_Form_3.pdf | 2013-11-18 |
17 | 926-del-2011-Correspondence-Others-(11-03-2013).pdf | 2013-03-11 |
18 | 926-del-2011-Form-3-(11-03-2013)3.pdf | 2013-03-11 |
19 | 926-del-2011-Abstract.pdf | 2011-10-05 |
20 | 926-del-2011-Claims.pdf | 2011-10-05 |
21 | 926-del-2011-Correspondence Others.pdf | 2011-10-05 |
22 | 926-del-2011-Description (Complete).pdf | 2011-10-05 |
23 | 926-del-2011-Form-1.pdf | 2011-10-05 |
24 | 926-del-2011-Form-2.pdf | 2011-10-05 |
25 | 926-del-2011-Form-3.pdf | 2011-10-05 |
26 | 926-del-2011-Form-5.pdf | 2011-10-05 |
1 | SearchStrategy_01-03-2018.pdf |